Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Defining Mechanisms for Cardiac Allograft Dysfunction to Improve Allograft Longevity and Survival in Heart-Transplant Patients

NCT03102125 is registered in ClinicalTrials.gov with Paul Kim as lead sponsor.

NCT NCT03102125
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03102125 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Defining Mechanisms for Cardiac Allograft Dysfunction to Improve Allograft Longevity and Survival in Heart-Transplant Patients
Lead sponsor
Paul Kim
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2019
Completion date
January 2, 2027
Enrollment
376 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart transplant failure and rejection